Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Psychiatric Care of Patients With Depression and Comorbid Substance Use Disorders. PDF $40.00
$40.00
× Placeholder Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies PDF $40.00
$40.00
× Placeholder Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF $40.00
$40.00
× Placeholder Massive, Previously Undetected Cancer Metastasis Revealed by Application of a Depot Antipsychotic: A Case Report PDF $40.00
$40.00
× Placeholder Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset PDF $40.00
$40.00
× Placeholder Efficacy and Safety of Aripiprazole in the Acute Treatment of Schizophrenia in Chinese Patients With Risperidone as an Active Control: A Randomized Trial PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe